Allergy Thera. Regulatory News (AGY)

Notification of Interest in Shares

1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ii

ALLERGY THERAPEUTICS PLC

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

X

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

An event changing the breakdown of voting rights

Other (please specify):

3. Full name of person(s) subject to the notification obligation: iii

Highclere International Investors Limited

4. Full name of shareholder(s)  (if different from 3.):iv

The Highclere International Investors International Smaller Companies Fund

The Highclere (Jesrsey) International Investors International Smaller Companies Fund

5. Date of the transaction and date on which the threshold is crossed or reached: v

22 JULY 2010

6. Date on which issuer notified:

23 JULY 2010

7. Threshold(s) that is/are crossed or reached: vi, vii

BELOW 4%

8. Notified details:

A: Voting rights attached to shares viii, ix

Class/type of shares

if possible using the ISIN CODE

Situation previous to the triggering transaction

Resulting situation after the triggering transaction

Number of Shares

Number of Voting Rights

Number of shares

Number of voting rights

% of voting rights x

Direct

Direct xi

Indirect xii

Direct

Indirect

ORD GBP 0.01

12,851,363

12,851,363

11,851,363

11,851,363

3.81%

BG00B02LCQ05

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financial instrument

Expiration date xiii

Exercise/ Conversion Period xiv

Number of voting rights that may be acquired if the instrument is exercised/ converted.

% of voting rights

N/A

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi

Resulting situation after the triggering transaction

Type of financial instrument

Exercise price

Expiration date xvii

Exercise/ Conversion period xviii

Number of voting rights instrument refers to

% of voting rights xix, xx

Nominal

Delta

Total (A+B+C)

Number of voting rights

Percentage of voting rights

11,851,363

3.81%

9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: xxi

Proxy Voting:

10. Name of the proxy holder:

Highclere International Investors Limited

11. Number of voting rights proxy holder will cease to hold:

N/A

12. Date on which proxy holder will cease to hold voting rights:

N/A

13. Additional information:

Highclere International Investors Limited ("Highclere") acts as an investment manager for the clients detailed in Question 4 anove (our "Clients"). In acting for our Clients, Highclere are given full discretion over their investments and are empowered to vote on their behalf. However, we do not act as our Client's custodian and terefore shares are not held in our name but in the nominee name of their custodian bank

14. Contact name:

Fergus Gilmore, Compliance Officer

15. Contact telephone number:

0207 258 9845